European Organisation for Research and Treatment of Cancer - EORTC: Lung Neoplasms trials

The registry lists 30 Lung Neoplasms studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 18Phase 3 9No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)WithdrawnNCT03319316Phase 2
• Pembrolizumab in Untreated Extensive SCLCCompletedNCT02580994Phase 2
• Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.SuspendedNCT02470065Phase 2
• SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial AccessCompletedNCT02214134
• LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLCStatus unknownNCT01795521Phase 2
• Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line ChemotherapyTerminatedNCT01208064Phase 2/3
• Sunitinib Malate in Treating Patients With Small Cell Lung CancerTerminatedNCT00953459Phase 2
• Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00458913Phase 2
• Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsCompletedNCT00433602
• Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by SurgeryTerminatedNCT00389688Phase 2
• Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung CancerCompletedNCT00103051Phase 2
• Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00091156Phase 3
• High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerTerminatedNCT00062335Phase 1
• Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung CancerTerminatedNCT00021112Phase 2
• Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung CancerCompletedNCT00016211Phase 3
• Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00006352Phase 3
• Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung CancerCompletedNCT00006082Phase 2
• Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung CancerCompletedNCT00005868Phase 2
• Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00005055Phase 2
• Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the PleuraCompletedNCT00004920Phase 3
• Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically RemovedCompletedNCT00004254Phase 2
• Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00004151Phase 2
• ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaCompletedNCT00003989Phase 2
• KRN7000 in Treating Patients With Solid TumorsWithdrawnNCT00003985Phase 1
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically RemovedTerminatedNCT00003803Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerCompletedNCT00003589Phase 3
• Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00003279Phase 3
• Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung CancerCompletedNCT00003062Phase 2
• Paclitaxel in Treating Patients With Lung CancerCompletedNCT00002972Phase 2
• Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00002623Phase 3